SESTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 1.574
AS - Asia 1.479
EU - Europa 925
SA - Sud America 414
AF - Africa 27
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.429
Nazione #
US - Stati Uniti d'America 1.517
SG - Singapore 727
IT - Italia 382
BR - Brasile 324
CN - Cina 248
DE - Germania 209
VN - Vietnam 193
IN - India 158
FI - Finlandia 99
GB - Regno Unito 76
AR - Argentina 41
CA - Canada 36
HK - Hong Kong 36
SE - Svezia 32
PL - Polonia 24
BD - Bangladesh 20
NL - Olanda 20
ID - Indonesia 17
EC - Ecuador 15
MX - Messico 15
ZA - Sudafrica 14
TR - Turchia 13
RU - Federazione Russa 12
EE - Estonia 11
ES - Italia 11
JP - Giappone 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
CL - Cile 9
FR - Francia 8
IL - Israele 7
MT - Malta 7
SA - Arabia Saudita 7
UA - Ucraina 7
UY - Uruguay 7
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CO - Colombia 5
IR - Iran 5
BG - Bulgaria 4
MY - Malesia 4
PK - Pakistan 4
PY - Paraguay 4
AT - Austria 3
EG - Egitto 3
PE - Perù 3
UZ - Uzbekistan 3
EU - Europa 2
IE - Irlanda 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
NP - Nepal 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BE - Belgio 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
TO - Tonga 1
Totale 4.429
Città #
Singapore 331
Munich 187
Dallas 169
Santa Clara 143
Chandler 124
Bengaluru 123
Hefei 122
Milan 90
Ashburn 89
Ho Chi Minh City 81
Chicago 58
Princeton 57
Lawrence 55
London 50
Helsinki 48
Boardman 47
Beijing 44
Turku 42
Los Angeles 39
Hanoi 36
Hong Kong 36
Rome 29
New York 27
Wilmington 27
Catanzaro 26
São Paulo 24
Warsaw 20
Rio de Janeiro 15
Assago 14
Brooklyn 11
Ottawa 11
Amsterdam 10
Atlanta 10
Bari 10
Des Moines 10
Naples 10
Olomouc 10
San Francisco 10
Tokyo 10
Guarulhos 9
Aversa 8
Chennai 8
Haiphong 8
Johannesburg 8
Messina 8
Montreal 8
Curitiba 7
St Louis 7
Baghdad 6
Biên Hòa 6
Boston 6
Campinas 6
Castrovillari 6
Charlotte 6
Cosenza 6
Guayaquil 6
Hanover 6
Jyväskylä 6
Montevideo 6
Palermo 6
Rende 6
Salvador 6
Thái Bình 6
Denver 5
Dhaka 5
Magé 5
Mexico City 5
Redmond 5
San Nicola Manfredi 5
Teresina 5
Udine 5
Ankara 4
Buenos Aires 4
Buffalo 4
Carapicuíba 4
Columbus 4
Council Bluffs 4
Ha Long 4
Hortolândia 4
Huế 4
Indore 4
Norwalk 4
Petaling Jaya 4
Phoenix 4
Pune 4
Quito 4
Rosario 4
San Jose 4
Toronto 4
Vancouver 4
Viamão 4
Belém 3
Can Tho 3
Cape Town 3
Casavatore 3
Costabissara 3
Cuiabá 3
Da Nang 3
Dubai 3
Duque de Caxias 3
Totale 2.563
Nome #
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 188
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 88
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 69
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 67
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 66
Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age 63
The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals 63
Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis 60
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 60
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 59
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance 58
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 58
Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes? 57
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects 56
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. 56
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 55
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 53
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans 53
Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes 53
Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance 52
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 51
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 50
Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome 49
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 48
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 47
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 47
Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance 47
Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status 46
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 46
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 44
HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study 44
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women 44
Anti-TNF therapy and plasma HDL cholesterol concentration (multiple letters) 42
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects 41
Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients 41
Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex 41
Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects 40
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial 39
Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice 39
One Hour-Post-load Plasma Glucose ≥155 mg/dl in Healthy Glucose Normotolerant Subjects Is Associated With Subcortical Brain MRI Alterations and Impaired Cognition: A Pilot Study. 39
COPD significantly increases cerebral and cardiovascular events in hypertensives 39
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes 39
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 38
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance 37
Immuno-Mediated Inflammation in Hypertensive Patients with 1-h Post-Load Hyperglycemia 37
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study 37
Ketogenic Diet-Induced Weight Loss is Associated with an Increase in Vitamin D Levels in Obese Adults. 37
Low Insulin-Like Growth Factor-1 Levels Are Associated With Myocardial Mechano-Energetic Efficiency in Older Individuals 36
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 36
Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes 36
Relationship between hemoglobin glycation index and myocardial mechano-energetic efficiency in non-diabetic individual 36
One-hour post-load plasma glucose levels are associated with elevated liver enzymes 36
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study 36
The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness. 36
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 36
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes 35
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 35
Competitive interaction between smoking and chronic obstructive pulmonary disease for explaining renal function reduction in hypertensive patients 35
Association of sodium–glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF 35
Whole blood viscosity is associated with reduced myocardial mechano-energetic efficiency in nondiabetic individuals. 35
Pathophysiological characteristics of subjects with intermediate hyperglycemia and type 2 diabetes identified by 1-hour plasma glucose during an oral glucose tolerance test 35
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival 35
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 35
Association between augmented levels of the gut pro-hormone Proneurotensin and subclinical vascular damage 34
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 34
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus 34
One-hour post-load glucose is associated with severity of hepatic fibrosis risk 33
Serum γ-glutamyltransferase concentration predicts endothelial dysfunction in naive hypertensive patients 33
Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects 33
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond 33
Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile 32
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus. 31
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes 30
Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes 30
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes 30
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure 29
Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062–1069 29
Prognostic role of serum albumin levels in patients with chronic heart failure 29
Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells 29
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus. 29
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals 28
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 28
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes 28
Osteopontin levels correlate with severity of diabetic cardiomyopathy in early stage of diabetes 28
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 28
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 28
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status 28
Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement 28
Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage 28
Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects 28
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes 28
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 27
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus 27
Impaired insulin sensitivity measured by estimated glucose disposal rate is associated with decreased myocardial mechano-energetic efficiency in non-diabetic individuals 27
One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden 26
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 26
New therapies for type 2 diabetes: Glucagon-Like Peptide 1 (GLP-1) analogs and Dipeptidyl Peptidase-4 inhibitors 26
Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-naïve hypertensive individuals. 25
Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects 25
Liver fibrosis is associated with an increased risk of non-fatal myocardial infarction 25
Totale 4.125
Categoria #
all - tutte 45.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 18 12 9 3 21 5 1 9
2021/2022191 0 1 4 23 22 5 20 35 24 23 34 0
2022/2023529 115 14 34 9 48 36 37 62 71 39 43 21
2023/2024485 86 70 26 47 44 76 16 11 10 16 37 46
2024/20251.448 168 14 32 34 120 171 140 64 168 33 208 296
2025/20261.820 218 351 367 522 362 0 0 0 0 0 0 0
Totale 4.614